<DOC>
	<DOCNO>NCT01226472</DOCNO>
	<brief_summary>This study enroll subject either Peripheral T-Cell Lymphoma ( PTCL ) Cutaneous T-Cell Lymphoma ( CTCL ) , include mycosis fungoides ( MF ) Sezary Syndrome ( SS ) , relapse achieve complete response study , KW-0761-001 .</brief_summary>
	<brief_title>Extension Study Subjects Who Relapsed After Complete Response Study KW-0761-001</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , T-Cell</mesh_term>
	<mesh_term>Lymphoma , T-Cell , Peripheral</mesh_term>
	<mesh_term>Lymphoma , T-Cell , Cutaneous</mesh_term>
	<criteria>1 . The subject relapse achieve complete response treatment KW 0761 PTCL CTCL study , KW0761001 . 2 . The subject Eastern Cooperative Oncology Group ( ECOG ) performance status score &lt; 2 study entry . 3 . The subject &gt; 18 year age . 4 . The subject adequate hematological function : absolute neutrophil count [ ANC ] &gt; 1,500 cells/uL platelet &gt; 100,000 cells/uL , except patient know bone marrow involvement absolute neutrophil count [ ANC ] must &gt; 1,000 cells/uL platelet &gt; 75,000 cells/uL . 5 . The subject adequate hepatic function : bilirubin ≤ 1.5 time specific institutional upper limit normal [ ULN ] ; aspartate transaminase [ AST ] alanine transaminase [ ALT ] ≤ 2.5 x ULN ≤ 5.0 x ULN presence know hepatic malignancy . 6 . The subject serum creatinine ≤1.5 x ULN calculate creatinine clearance &gt; 60 mL/min . 7 . Subjects MF history staphylococcus colonization eligible provide continue receive stable dos prophylactic antibiotic . 1 . The subject receive type treatment disease since complete study , KW0761001 . 2 . The subject significant uncontrolled intercurrent illness include , limited : uncontrolled infection require antibiotic ; clinically significant cardiac disease ( class III IV New York Heart Association [ NYHA ] classification ) ; unstable angina pectoris ; angioplasty , stenting , myocardial infarction within 6 month ; uncontrolled hypertension ( systolic blood pressure &gt; 160 mmHg , diastolic BP &gt; 100 mmHg , find two consecutive measurement separate 1 week period ) despite two antihypertensive medication ; clinically significant cardiac arrhythmia ; uncontrolled diabetes . 3 . Subjects immunomodulatory drug , ( low dose corticosteroid equivalent daily dose 10 mg prednisone 4 . The subject psychiatric illness , disability social situation would compromise subject 's safety ability provide consent , limit compliance study requirement . 5 . The subject experience allergic reaction monoclonal antibody therapeutic protein . 6 . Subjects active herpes simplex herpes zoster . 7 . Subjects know autoimmune disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>PTCL</keyword>
	<keyword>CTCL</keyword>
	<keyword>MF</keyword>
	<keyword>SS</keyword>
</DOC>